Aptevo Therapeutics Inc. Investing Cash Flow
Aptevo Therapeutics Inc. (APVO) reported Investing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- Aptevo Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$29.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$4.00K derived: sum of 2 quarters · filed 2024-03-05 | -$29.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$29.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$25.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$131.00K derived: sum of 2 quarters · filed 2023-03-30 | -$522.00K derived: sum of 3 quarters · filed 2023-03-30 | -$713.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$404.00K derived: sum of 2 quarters · filed 2022-11-10 | -$595.00K 10-Q · filed 2022-11-10 | -$683.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$582.00K 10-Q · filed 2022-08-11 | -$670.00K derived: sum of 3 quarters · filed 2022-08-11 | -$670.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$191.00K 10-Q · filed 2022-05-12 | -$279.00K derived: sum of 2 quarters · filed 2022-05-12 | -$279.00K derived: sum of 3 quarters · filed 2022-05-12 | -$279.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$88.00K derived: sum of 2 quarters · filed 2022-03-24 | -$88.00K derived: sum of 3 quarters · filed 2022-03-24 | $28.03M 10-K · filed 2022-03-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $28.12M 10-Q · filed 2021-11-12 | $28.12M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $28.12M 10-Q · filed 2021-08-12 | $28.12M derived: sum of 3 quarters · filed 2021-08-12 | $32.37M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $28.12M 10-Q · filed 2021-05-11 | $28.12M derived: sum of 2 quarters · filed 2021-05-11 | $32.37M derived: sum of 3 quarters · filed 2021-05-11 | $32.37M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $4.25M derived: sum of 2 quarters · filed 2021-03-31 | $4.25M derived: sum of 3 quarters · filed 2021-03-31 | $4.10M 10-K · filed 2021-03-31 |
| 2019-09-30 | $4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $4.25M derived: sum of 2 quarters · filed 2020-11-10 | $4.10M 10-Q · filed 2020-11-10 | $13.14M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$153.00K 10-Q · filed 2020-08-14 | $8.89M derived: sum of 3 quarters · filed 2020-08-14 | $36.84M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$153.00K 10-Q · filed 2020-05-13 | $8.89M derived: sum of 2 quarters · filed 2020-05-13 | $36.84M derived: sum of 3 quarters · filed 2020-05-13 | $49.13M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $36.99M derived: sum of 2 quarters · filed 2020-03-25 | $49.28M derived: sum of 3 quarters · filed 2020-03-25 | $72.80M 10-K · filed 2020-03-25 |
| 2018-09-30 | $27.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $40.24M derived: sum of 2 quarters · filed 2019-11-07 | $63.76M 10-Q · filed 2019-11-07 | $9.91M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $12.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $35.81M 10-Q · filed 2019-08-09 | -$18.03M derived: sum of 3 quarters · filed 2019-08-09 | $47.33M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $23.51M 10-Q · filed 2019-05-09 | -$30.33M derived: sum of 2 quarters · filed 2019-05-09 | $35.03M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$53.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $11.52M derived: sum of 2 quarters · filed 2019-03-18 | $29.46M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $65.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $83.30M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $17.94M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |